“…[13][14][15] The exposure of dead cells to TAAs can enhance antigen-specic T-cell responses and the released DAMPs, which can induce dendritic cell (DC) maturation, trigger T-cell activation, and consequently trigger anti-tumor immune response. 16,17 Considering that photoimmunotherapy, with high spatiotemporal precision and excellent safety, has emerged as a promising tool for solid tumor ablation and ICD induction, and therefore various phototherapeutic agents, including aggregation-induced emission luminogens, [18][19][20] nanosized metal-organic frameworks, [21][22][23] black phosphorous (BP) nanomaterial, [24][25][26] carbon nanomaterial, [27][28][29] up-conversion nanoparticles, 18,30,31 and subcellular targeted nanoparticles (NPs), 15,32,33 have been designed and synthesized for photo-immunotherapy. However, treating tumors with phototherapy alone is not efficient to induce durable and robust tumor immunogenicity against tumor recurrence and metastasis.…”